Stem cell therapy - Wikipedia, the free encyclopedia Stem cell therapy is an intervention strategy that introduces new adult stem cells into damaged tissue in order to treat disease or injury. Many medical researchers believe that stem cell treatments have the potential ...
The Definitive Stem Cell Journal List | Knoepfler Lab Stem Cell ... 14 Oct 2013 ... With the excitement surrounding stem cells perhaps it is not a shocker that the number of journals ...
Stem cell journal impact factors: how does your favorite ... 2013年4月16日 - The number of articles on stem cells and the number of journals focused ... Are all of these stem cell journals attaining a decent impact factor?
Hematopoietic Stem Cell Transplantation - Diseases & Conditions - Medscape Reference Hematopoietic stem cell transplantation (HSCT) involves the intravenous (IV) infusion of autologous or ...
Stem Cells Translational Medicine Concise Review: Breast Cancer Stem Cells: Regulatory Networks, Stem Cell Niches, and Disease Relevance.
JTM | Full text | Risk factors in the development of stem cell therapy Risks associated with stem cell therapy depend on many risk factors. A risk is defined as a combination of the probability of occurrence of harm and the severity of that harm [35,36]. A risk factor or hazard is defined as a potential source of harm [35,37
Journal of Translational Medicine Journal of Translational Medicine is an open access journal publishing articles focusing on information derived from human experimentation so as to optimise the communication between basic and clinical science. The journal covers all areas of translationa
Beyond the Dish | A developmental biologist muses about stem cells and regenerative medicine, the et Wells’ gastric organoids are a significant advance in gastroenterological research because distinct differences in development and architecture of the adult stomach limit the reliability of mouse models for studying human stomach development and disease.
Home | Haematologica Haematologica is the journal of the European Hematology Association, reporting important novel findings in basic, clinical & translational research in the broad field of hematology. the oldest hematology journal founded by Dr. Adolfo Ferrata in 1920 publi
Giostar Stem Cells Research Mr. Deven Patel – President, CEO and Co-founder Mr. Deven Patel is the President, CEO and Cofounder of GIOSTAR. He has also served as the CEO, President and Board of Directors in highly comprehensive environment of Healthcare ...
